Recombinant Rat S100A5 Protein，His

S100A5 is a member of the S100 protein family, characterized by its ability to bind calcium and zinc ions, which play crucial roles in various cellular processes. Research into S100A5 has gained attention due to its involvement in several pathological conditions, including cancer progression, inflammation, and neurodegenerative diseases. The protein is believed to participate in regulating cellular growth, differentiation, and migration, making it a potential biomarker and therapeutic target. Notably, studies have shown that S100A5 can influence tumor microenvironments and adjacent signaling pathways, contributing to tumor cell survival and metastasis. Additionally, its expression levels have been correlated with disease prognosis, highlighting its significance in clinical settings. Given this backdrop, recombinant S100A5 protein production has emerged as a pivotal area of research, facilitating the study of the protein's structure-function relationships and its interactions with other biomolecules. Through recombinant technology, the availability of pure S100A5 allows for detailed functional assays and the development of inhibitors or modulators, advancing the understanding of its role in health and disease. Overall, the continued exploration of S100A5 at the molecular level promises to uncover novel therapeutic strategies and improve diagnostic approaches in various diseases.